title: Effects of low casein and fish oil on hyperlipidemia and proteinuria in nephritic rats.
abstract: The effects of amino acid-fortified low casein and fish oil (FO) diets on hyperlipidemia and proteinuria were studied in rats with nephrotoxic serum nephritis. After an antiserum injection, rats were maintained for 14 d on four different experimental diets: a 20% casein diet containing corn oil (CO) or FO, or an 8% casein diet supplemented with cystine plus threonine containing CO or FO. The 8% casein diets reduced urinary protein excretion in nephritic rats without inducing severe growth retardation or fatty liver compared with the basal 20% casein diets. Both the 8% casein diet and the FO diet decreased serum cholesterol, triglyceride and phospholipid levels in nephritic rats, and nonesterified fatty acid levels were decreased by FO feeding. In nephritic animals, hepatic cholesterol synthesis was decreased by the 8% casein diets compared with the 20% casein diets, and tended to be reduced by FO feeding between groups at the same casein levels. No effect of diet was observed on fatty acid synthesis among the nephritic rats. FO administration to the nephritic animals suppressed fecal steroid excretion. While lipoprotein lipase activity was unchanged among the nephritic rats, hepatic triglyceride lipase activity was reduced by either the 8% casein or FO diet. The results suggest that the hypolipidemic action of low casein diets may, at least in part, be due to reduced hepatic cholesterol synthesis and suppressed triglyceride secretion from the liver. They also suggest that the hypolipidemic action of FO may, at least in part, be due to reduced hepatic cholesterol synthesis and decreased fatty acid mobilization from peripheral adipose tissue.
authors.affiliation: Department of Applied Biological Science, Tokyo Noko University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Fujisawa
authors.forename: K
authors.initials: K
authors.lastname: Yagasaki
authors.forename: R
authors.initials: R
authors.lastname: Funabiki
mesh_terms: D000821:Animal Feed; D000818:Animals; D001835:Body Weight; D002364:Caseins / Q000008:administration & dosage*; D002784:Cholesterol / Q000032:analysis; D005395:Fish Oils / Q000494:pharmacology*; D006949:Hyperlipidemias / Q000150:complications / Q000178:diet therapy*; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000737:chemistry; D008297:Male; D009393:Nephritis / Q000150:complications; D010743:Phospholipids / Q000032:analysis; D011506:Proteins / Q000032:analysis; D011507:Proteinuria / Q000150:complications / Q000178:diet therapy*; D051381:Rats; D017208:Rats, Wistar; D012709:Serum Albumin / Q000032:analysis; D014280:Triglycerides / Q000032:analysis
chemical_list: D002364:Caseins; D005395:Fish Oils; D008055:Lipids; D010743:Phospholipids; D011506:Proteins; D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol